• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Response to Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline".

作者信息

Eastell Richard, Rosen Clifford J

机构信息

Academic Unit of Bone Metabolism, Mellanby Centre for Bone Research and Metabolic Bone Centre, Northern General Hospital, Sheffield, United Kingdom.

Department of Medicine, Tufts University School of Medicine, Maine Medical Center Research Institute, Scarborough, Maine.

出版信息

J Clin Endocrinol Metab. 2019 Aug 1;104(8):3537-3538. doi: 10.1210/jc.2019-00777.

DOI:10.1210/jc.2019-00777
PMID:30998238
Abstract
摘要

相似文献

1
Response to Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline".对致编辑信的回复：“绝经后女性骨质疏松症的药物治疗：内分泌学会临床实践指南”
J Clin Endocrinol Metab. 2019 Aug 1;104(8):3537-3538. doi: 10.1210/jc.2019-00777.
2
Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: an Endocrine Society Clinical Practice Guideline".致编辑的信：“绝经后女性骨质疏松症的药物治疗：内分泌学会临床实践指南”
J Clin Endocrinol Metab. 2020 Jan 1;105(1). doi: 10.1210/clinem/dgz131.
3
Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline".致编辑的信：“绝经后女性骨质疏松症的药物治疗：内分泌学会临床实践指南”
J Clin Endocrinol Metab. 2019 Nov 1;104(11):5181-5182. doi: 10.1210/jc.2019-01017.
4
Letter to the Editor: "Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Clinical Practice Guideline".
J Clin Endocrinol Metab. 2019 Aug 1;104(8):3535-3536. doi: 10.1210/jc.2019-00747.
5
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society Guideline Update.绝经后妇女骨质疏松症的药物治疗：内分泌学会指南更新。
J Clin Endocrinol Metab. 2020 Mar 1;105(3). doi: 10.1210/clinem/dgaa048.
6
Time to Benefit of Bisphosphonate Therapy for the Prevention of Fractures Among Postmenopausal Women With Osteoporosis: A Meta-analysis of Randomized Clinical Trials.绝经后骨质疏松症妇女应用双膦酸盐治疗预防骨折的获益时间：一项随机临床试验的荟萃分析。
JAMA Intern Med. 2022 Jan 1;182(1):33-41. doi: 10.1001/jamainternmed.2021.6745.
7
Letter to the Editor: "Dietary Calcium Intake and Bone Loss Over 6 Years in Osteopenic Postmenopausal Women".
J Clin Endocrinol Metab. 2019 Sep 1;104(9):3609. doi: 10.1210/jc.2019-00785.
8
Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline.绝经后妇女骨质疏松症的药物治疗：内分泌学会临床实践指南*。
J Clin Endocrinol Metab. 2019 May 1;104(5):1595-1622. doi: 10.1210/jc.2019-00221.
9
Management of osteoporosis in postmenopausal women: the 2021 position statement of The North American Menopause Society.绝经后女性骨质疏松症的管理：北美更年期协会2021年立场声明
Menopause. 2021 Sep 1;28(9):973-997. doi: 10.1097/GME.0000000000001831.
10
Diagnosis and management of osteoporosis in postmenopausal women in Gulf Cooperation Council (GCC) countries: consensus statement of the GCC countries' osteoporosis societies under the auspices of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO).海湾合作委员会（GCC）国家绝经后妇女骨质疏松症的诊断和管理：在欧洲临床和经济骨质疏松症和骨关节炎学会（ESCEO）的支持下，GCC 国家骨质疏松症学会的共识声明。
Arch Osteoporos. 2020 Jul 22;15(1):109. doi: 10.1007/s11657-020-00778-5.

引用本文的文献

1
Regulation of bone and fat balance by Fructus Ligustri Lucidi in ovariectomized mice.女贞子对去卵巢小鼠骨与脂平衡的调节作用。
Pharm Biol. 2023 Dec;61(1):391-403. doi: 10.1080/13880209.2023.2168019.
2
Discontinuing Denosumab: Can It Be Done Safely? A Review of the Literature.停用地舒单抗：能否安全停药？文献复习。
Endocrinol Metab (Seoul). 2022 Apr;37(2):183-194. doi: 10.3803/EnM.2021.1369. Epub 2022 Apr 14.
3
Outcomes of different minimally invasive surgical treatments for vertebral compression fractures: An observational study.
不同微创外科治疗椎体压缩骨折的疗效：一项观察性研究。
World J Clin Cases. 2021 Nov 6;9(31):9509-9519. doi: 10.12998/wjcc.v9.i31.9509.
4
Faster Lumbar Spine Bone Loss in Midlife Predicts Subsequent Fracture Independent of Starting Bone Mineral Density.中年腰椎骨丢失速度加快与起始骨密度无关，可预测随后发生骨折。
J Clin Endocrinol Metab. 2021 Jun 16;106(7):e2491-e2501. doi: 10.1210/clinem/dgab279.